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Abstract 
A major development over the past two decades has been the realization that 
free radical induced lipid peroxidation and DNA damage are associated with 
major health problems, e.g. cancer and ageing. Plant-derived antioxidants are 
increasingly found beneficial in protecting against these diseases. Celtis 
australis L. and Celtis occidentalis L. are two plants that have a variety of uses 
in folk medicine but have not been evaluated before for their antioxidant and 
cytotoxic properties. Therefore,  the extracts of both plants' leaves were 
investigated for these activities, as well as isolation of the bioactive compounds 
responsible for the activities. Molecular  structures of the compounds were 
elucidated by UV, HRESIMS, 1D (
1H and 
13C) and 2D (
1H-
13C HSQC and 
1H-
13C HMBC) NMR analyses.  The ethanolic and aqueous extracts, n-butanol 
fractions and the isolated major compound were tested for their antioxidant 
activity using DPPH radical scavenging assay,  xanthine oxidase-induced 
generation of superoxide radical and lipid peroxidation assay by thiobarbituric 
acid-reactive substances (TBARS) method using rat tissue homogenates. 
Cytotoxic activities were studied using standard MTT assay. A novel flavonoid 
C-triglycoside, 4'''-α-rhamnopyranosyl-2''-O-β-D-galactopyranosylvitexin,  was 
isolated from both plants' leaves, together with seven known flavonoids. The 
n-butanol fractions and the major compound 2''-O-β-galactopyranosylvitexin 
showed significant antioxidant activities, more pronounced than the tested 964  T. S. El-Alfy et al.:   
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standards BHT and DL-α-tocopherol in most tests. All extracts showed variable 
cytotoxic activities. This study provides strong evidence for the antioxidant and 
cytotoxic activities of the extracts of Celtis australis L. and Celtis occidentalis L. 
leaves, which were  attributed to the polar  n-butanol fractions and the major 
isolated flavonoid 2''-galactosylvitexin. 
Keywords 
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Introduction 
Celtis australis L., Family Ulmaceae (Mediterranean hackberry), is a deciduous tree native 
to the Mediterranean region and southwestern Asia [1]. Decoctions of the leaves and fruits 
were used to astringe the mucous membrane in peptic ulcers, diarrhoea, and dysentery 
and as a remedy for heavy menstrual bleeding and colic [2, 3]. In Indian traditional 
medicine, the plant is an important remedy for bone fracture, contusions, sprains and joint 
pains [4].  
Celtis occidentalis L., Family Ulmaceae (Hackberry, American Hackberry), is a medium-
size deciduous tree native to North America. Native Americans used decoctions prepared 
from the bark as an aid in menses and to relieve sore throat and used the wood extract in 
treating jaundice [5, 6]. 
Previous investigations reported the isolation of acacetin 7-O-glucoside, isovitexin, 
cytisoside, 2''-α-rhamnopyranosylvitexin and 2''-α-rhamnopyranosyl-7-O-methylvitexin from 
the leaves of Celtis australis  L.  [7, 8], a sulphonated phenolic compound (celtisanin), 
apigenin, quercetin and quercetin-glucoside from the fruits [9] and a bacteriohopanoid from 
the barks [10]. Nothing was reported concerning Celtis occidentalis L. 
Antioxidant and cytotoxic activities were reported before with other Celtis species  e.g. 
Celtis philippinensis Blanco [11], Celtis africana Burm. f. [12], and Celtis iguanae (Jacq.) 
Sarg.  [13]. According  to  the available literature, these activities were not investigated 
before in Celtis australis L. and Celtis occidentalis L. leaves. 
Known isolated flavonoid C-glycosides e.g. vitexin, isovitexin, orientin and isoorientin were 
investigated before for their antioxidant activities [14–16].  
Therefore, this study reports the isolation of a new flavonoid C-glycoside 8-(4'''-α-
rhamnosyl-2''-O-β-D-galactopyranosylvitexin) along with seven known flavonoid glycosides  
(1–7). The antioxidant properties of the ethanolic and aqueous extracts were investigated 
since most of the herbal products available in the market are found in the form of tea bags 
or crude ethanolic extracts. Also the flavonoid-rich n-butanol fractions of the leaves as well 
as the major isolated flavonoid 6, were investigated for their antioxidant properties using 
1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging assay, xanthine oxidase-induced 
generation of superoxide radical assay and measurement of FeSO4/H2O2-stimulated lipid 
peroxidation in rat tissue homogenates. The cytotoxic activity against different human cell 
lines was also studied.   Flavonoids from two Celtis species and their Biological Activities   965 
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Results and Discussion 
Phytochemical investigation 
Compound 8 was obtained as a yellow powder. The positive ESI-MS spectrum gave a 
molecular ion at m/z 741 (M + H)
+, whereas the negative ESI-MS (M − H)
− ion at m/z 739. 
These data together with the 
13C NMR spectrum showing 33 signals indicated the 
molecular formula to be C33H40O19. The UV spectrum showed characteristic flavone 
absorption at 272 and 330 nm [17]. The 
1HNMR spectrum indicated the presence of an 
apigenin skeleton substituted at C-8 through C-C linkage confirmed by the appearance of 
H-6 at δ 6.21. The appearance of three anomeric proton signals suggested a triglycoside 
moiety.  The  first  anomeric  proton  at  δ  4.76,  J=9.9  Hz  was  assigned  to  a  β-D-gluco-
pyranose, the second anomeric proton at δ 3.99, J=9 Hz was assigned to a β-D-galacto-
pyranose sugar while an α-L-rhamnopyranose moiety was represented by an anomeric 
proton  at  δ  4.90  and  a  doublet  at  δ  1.19,  J=6  Hz  assigned  for  CH3-6''''  of the 
rhamnopyranose.  
The positive-ion MS/MS of compound  8  showed fragment ion peak at m/z 594.3 
(M+H−146)
+ assignable to the loss of a desoxyhexose moiety from the parent ion which 
was suggestive of a linear triglycoside moiety. The desoxyhexose identified as rhamnose 
was found to be attached at position C-4'''  of the galactose sugar evidenced by its 
downfield shifting to δ 67.2 together with the upfield shifting of the anomeric proton to δ 
101.4. HBMC spectrum was used to identify the carbon and proton signals. Correlations 
appearing between H-1''/C-8 confirmed attachment of the sugar unit through C-linkage to 
C-8 of the apigenin moiety. Also, correlations between 2''-H/C-1''' and 1'''-H/C-2'' confirmed 
the linkage of the galactose to C-2'' of glucose. All these data were consistent with the 
structure apigenin-8-C-(4'''-O-rhamnosyl-2''-galactosyl)-glucopyranoside, (4'''-α-L-rham-
nosyl-2''-O-β-D-galactopyranosylvitexin). To the best of our knowledge, this is the first 
report for the isolation of this compound in nature. 
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Fig. 1.   Structure and atom numbering of compound 8. 
Compounds 1 and 2 were identified as vitexin and orientin [18]; compounds 3 and 4 were 
identified as isovitexin and isoorientin [18–20]; compound 5 was identified as rutin [17, 21]. 
ESIMS and NMR analyses (1D [
1H and 
13C] and 2D [
1H-
13C HSQC and 
1H-
13C HMBC]) 
identified compound 6 as 2''-O-β-galactopyranosylvitexin and compound 7 as 2''-O-β-D-966  T. S. El-Alfy et al.:   
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galactopyranosylorientin. Their data were compared with that reported in literature [22, 23]. 
Compounds (1–3 and 5–7) were isolated for the first time from genus Celtis. Both studied 
Celtis species showed a similar flavonoidal pattern differing only in the amount present. 
Tab. 1. 
1H and 
13C NMR data of compound 8 (DMSO-d6, 300, 75 MHz) 
No.  Compound 8  No.  Compound 8 
  δH
a      δH
a  No. 
2    163.7  3''    75.8 
3  6.70, s  102.5  4''    70.8 
4    182.0  5''    81.5 
5    160.1  6''    61.1 
6  6.21, s  97.9  2''-O-Gal 1'''  3.99, d (9)  101.4 
7    162.4  2'''    72.3 
8    104.3  3'''    74.0 
9    156.3  4'''    67.2 
10    103.9  5'''    75.0 
1'    121.8  6'''    58.1 
2'  8.01, d (8.7)  128.8  4'''-O-Rha 1''''  4.90, s  100.2 
3'  6.89, d (9)  115.8  2''''    70.4 
4'    160.9  3''''    70.6 
5'  6.89, d (9)  115.8  4''''    73.2 
6'  8.01, d (8.7)  128.8  5''''    68.1 
8-C-Glc 1''  4.76, d (9.9)  71.7  6''''  1.19, d (6)  17.5 
2''    78.9       
a Coupling constants (J in Hertz) are in parentheses.
 
 
In-vitro biological evaluation 
DPPH radical scavenging activity [24] 
All the tested samples had significant scavenging effects on the DPPH radical. The results 
recorded in table 2 indicated that 2''-O-β-galactopyranosylvitexin showed the highest 
activity among all the tested samples (84.8%), followed by the n-butanol fraction (70.3%) 
and the ethanolic extract (67.2%), and they were higher than α-tocopherol and BHT (66.5 
and 55.3%, respectively).  The results obtained for the n-butanol fractions and 
2''-galactosylvitexin indicated that the flavonoidal content (C-flavonoid glycosides) is 
responsible for the scavenging effects,  and this could be attributed to their hydrogen 
donating activity. In general, the phenolic OH is considered a scavenger of free radicals, 
and it consequently exhibits antioxidative activity [25].  
Xanthine oxidase-induced generation of superoxide radical [26] 
The tested samples inhibited superoxide-induced reduction of nitroblue tetrazolium, which 
depends on direct inhibition of xanthine oxidase enzyme as shown in table 2. The major 
isolated flavonoid, 2''-O-β-galactopyranosylvitexin,  showed the highest activity with 
IC50=24.2 μM, followed by the n-butanol fraction of both plants with IC50=27.2 μM and 38.5 
μM, respectively.    Flavonoids from two Celtis species and their Biological Activities   967 
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Tab. 2.   Effects of the tested samples on the in vitro free radical generation 
Bioassay  DPPH % inhibition  Xanthine oxidase
a 
IC50 (μM) 
Ethanolic extract (CA)  67.2 ± 2.10  76.8 ± 2.90 
Ethanolic extract (CO)  58.5 ± 1.50  92.1 ± 3.55 
Aqueous extract (CA)  55.6 ± 2.10  70.2 ± 2.18 
Aqueous extract (CO)  48.5 ± 1.35  95.5 ± 3.70 
n-butanol fraction (CA)  70.3 ± 2.20  27.2 ± 2.10 
n-butanol fraction (CO)  65.9 ± 1.96  38.5 ± 1.78 
2''-O-β-galactopyranosylvitexin  84.8 ± 2.44  24.2 ± 1.95 
DL-α-tocopherol  66.5 ± 2.75  78.5 + 2.88 
BHT  55.3 ± 1.50  130.7 + 4.35 
Allopurinol  –  18.0 ± 0.25 
a Uric acid production for controls was (61.0 ± 1.9 nmol/min). 
All tested samples and positive controls were tested at 100 μg/mL. 
Values are presented as mean ± SE of 3-test sample observation. P < 0.05 for all values. 
CA = Celtis australis L.; CO = Celtis occidentalis L. 
 
Phenolic compounds are known to inhibit generation of the superoxide anion radical (O
2•−) 
in the hypoxanthine-xanthine oxidase system. The radical scavenging action of these 
phenolic compounds is through the formation of stable free radicals, which contribute to 
the inhibitory effects on lipid peroxidation and participate in the inhibition of (O
2•−) 
generation. Since the n-butanol fractions is rich in apigenin and luteolin derivatives e.g. 
isovitexin, orientin and isoorientin which were  reported  to have activities  regarding 
inhibition of xanthine oxidase enzyme [16, 27]. Therefore, these  fractions  could be 
effective as natural antioxidants, through their double ability to inhibit xanthine oxidase 
activity and superoxide anion production, and could be considered an effective strategy in 
the treatment of inflammation. 
FeSO4/H2O2-stimulated lipid peroxidation in rat tissue homogenate [28, 29] 
For rat tissue homogenate (brain, heart and liver), the unstimulated control experiments 
i.e.  the amount of thiobarbituric reactive substance (TBARS)  formed in rat tissue 
homogenate (brain, heart and liver) were (0.44 ± 0.05, 0.25 ± 0.03 and 0.19 ± 0.02 nmol 
malondialdehyde,  MDA/mg  protein, respectively).  After induction with FeSO4/H2O2,  the 
amount of TBARS  increased to 0.90  ±  2.55,  0.60  ±  2.16 and 0.52  ±  1.25  nmol 
malondialdehyde,  MDA/mg  protein,  for  brain, heart and liver, respectively.  The tested 
samples significantly reduced malondialdehyde (MDA) formation in the presence of 
FeSO4-H2O2  in tissue homogenates indicating anti-lipid peroxidation activities. The 
inhibition percentages were in the range of (55.10–80.85%), (52.40–71.50%) and (43.90–
78.25%) in brain, heart and liver rat tissue homogenates, respectively as recorded in 
table 3.  
 
 968  T. S. El-Alfy et al.:   
Sci Pharm. 2011; 79: 963–975 
Tab. 3.   Inhibition effects of the tested samples on FeSO4/H2O2-stimulated lipid 
peroxidation (MDA production) in rat tissue homogenates in vitro 
Bioassay 
Sample 
Inhibition (%)
a 
Brain  Heart  Liver 
Ethanolic extract (CA)
b  80.85 ± 1.15  55.30 ± 1.80  68.30 ± 1.83 
Ethanolic extract (CO)
b  75.60 ± 1.97  50.22 ± 1.80  70.90 ± 2.15 
Aqueous extract (CA)
b   55.10 ± 2.28  52.40 ± 2.18  43.90 ± 2.25 
Aqueous extract (CO)
b  43.50 ± 1.55  48.75 ± 1.28  32.75 ± 1.80 
n-butanol fraction (CA)
b  66.18 ± 2.10  54.10 ± 1.80  49.75 ± 1.76 
n-butanol fraction (CO)
b  64.82 ± 2.05  60.05 ± 1.85  53.10 ± 1.80 
2''-O-β-galactopyranosylvitexin
c  80.78 ± 3.12  71.50 ± 2.35  78.25 ± 3.10 
DL-α-tocopherol
b  62.90 ± 2.18  58.70 ± 1.80  71.10 ± 2.25 
BHT
b  52.48 ± 1.72  43.23 ± 1.65  53.20 ± 1.65 
a Values are presented as mean ± SE of 3-test sample observations, P < 0.05 for all values; 
b 200 μg/mL; 
c 100 μg/mL; CA = Celtis australis L.; CO = Celtis occidentalis L. 
 
It was interesting to note that the inhibition effects produced by the tested samples were 
more pronounced for brain tissue homogenates than liver and heart tissue homogenates, 
which could be especially beneficial in treatment of Alzheimer's disease in cases with 
oxidative stress due to elevated levels of TBARS [30]. The ethanolic extract and 2''-O-β-
galactopyranosylvitexin showed the highest inhibition activity against FeSO4/H2O2-
stimulated lipid peroxidation in brain rat tissue homogenate (80.85 and 80.78%), 
respectively, which was higher than both reference standards. Since  DL-α-tocopherol is 
thought to be associated with lipid-rich membranes; its  anti-oxidative  ability  is highly 
effective in protecting membranes against lipid peroxidation, as peroxyl and alkoxyl 
radicals. The data obtained from the present study indicates that the tested extracts have 
an anti-lipid peroxidative character with similar reaction mechanisms to those of   
DL-α-tocopherol.  
Tab. 4.   ED50 (μg/mL) of the tested samples on the selected cell lines
a 
 
 
Sample  HEP-G2  CCRF-CEM  COLO 205  NCI-N87  NIH-OVAR-3 
Ethanolic 
extract (CA)  26.10 ± 0.20  > 100  25.65 ± 0.20  45.15 ± 0.25  77.65 ± 0.52 
Ethanolic 
extract (CO)  39.85 ± 0.25  > 100  24.80 ± 0.20  15.80 ± 0.05  68.50 ± 0.45 
Aqueous 
extract (CA)  26.90 ± 0.20  77.50 ± 0.53  63.45 ± 0.40  35.10 ± 0.15  72.77 ± 0.48 
Aqueous 
extract (CO)  18.60 ± 0.08  79.54 ± 0.47  26.60 ± 0.25  23.55 ± 0.10  76.10 ± 0.55 
a Values are presented as mean ± SE of 2 test sample observation, compared with that of control group (p < 
0.05) for all values; HEP-G2…Human hepatocellular carcinoma; CCRF-CEM…leukemia carcinoma; COLO 
205…colon adenocarcinoma; NIH-OVCAR-3…ovary adenocarcinoma; NCI-N87…gastric carcinoma; 
CA…Celtis australis L.; CO…Celtis occidentalis L.   Flavonoids from two Celtis species and their Biological Activities   969 
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Cytotoxic activity [31] 
As shown in table 4, human hepatocellular carcinoma (HEP-G2), colon adenocarcinoma 
(COLO 205) and gastric carcinoma (NCI-N87) were the most sensitive of all cell lines 
examined to the activities of the extracts, followed by the ovary adenocarcinoma 
(NIH:OVCAR-3). The aqueous extract of Celtis occidentalis L. leaves showed the 
strongest activity against HEP-G2 (ED50= 18.60 μg/mL), while the plant's ethanolic extract 
was most active against COLO 205 and NCI-N87 (ED50= 24.80 and 15.80 μg/mL, 
respectively).  
Conclusions 
This study provides strong evidence for the antioxidant activities of the leaves’ ethanolic 
extracts of Celtis australis L. and Celtis occidentalis L. that could be considered as two 
valuable medicinal plant species. The results obtained for the n-butanol fractions and the 
major isolated flavonoid, 2''-galactosylvitexin, indicated that the C-flavonoid glycosides in 
both studied plants are responsible for the scavenging effects through several 
mechanisms  like  hydrogen donating activity, inhibition of xanthine oxidase activity and 
superoxide anion production, as well as protection of membranes against lipid 
peroxidation.  This could be potentially useful for the treatment of major free radical-
induced degenerative diseases including brain dysfunction, inflammation, liver disorders 
and cancer. Further in-vivo studies could be done to support this point of view.  
Experimental 
Plant material 
Celtis australis L. and Celtis occidentalis L. leaves were collected from El-Orman Botanical 
Garden and the Agricultural museum, Giza, Egypt. Dr. Mohamed El Gebaly, Taxonomist, 
National Research Center kindly verified identity of the plant material. Voucher specimens 
(G-02 and G-03) were kept in the Department of Pharmacognosy, Faculty of Pharmacy, 
Cairo University, Egypt. 
Chemicals 
1,1-Diphenyl-2-picrylhydrazyl (DPPH), butylated hydroxytoluene (BHT), 2-thiobarbituric 
acid, ferrous sulphate, hydrogen peroxide, xanthine oxidase from bovine milk, allopurinol, 
nitroblue tetrazolium, 3-(4,5-dimethyl-1,3-thiazol-2-yl)-2,5-diphenyl-2H-tetrazol-3-ium 
bromide (MTT) and sodium 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonate (HEPES, 
for Kreb's buffer) (Sigma, St. Louis, Mo, USA); coomassie plus protein assay reagent and 
albumin standard (Pierce, Rockford, IL, USA). DL-α-tocopherol (Nacalai, Tesuque, Tokyo, 
Japan); L-glutamine, 1% non-essential amino acids and 1% sodium pyruvate (Bio 
Whittaker, Walkersville, MD, USA). 10 % fetal bovine serum (FBS) (Gibco Br L, Rockville, 
MD, USA). TLC was performed on pre-coated sheets with silica gel F254 (Fluka,Sigma-
Aldrich, Germany).Column chromatography was performed over silica gel H 60 for VLC 
(Sigma, St. Louis, Mo, USA.), sephadex LH-20 (Pharmacia Fine Chemicals, AB Uppsala, 
Sweden), polyamide and silica gel 60 (Fluka, Sigma-Aldrich, Germany). All other 
chemicals used were of analytical grade. 
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Animals 
Male Wistar rats (250–300 g) were handled according to international regulations. They 
were allowed to take standard laboratory diet and water ad libitum, and the animals were 
maintained at 24 °C with 12 h light period.  
Cell lines and culture media 
Human hepatocellular carcinoma (HEP-G2), leukemia carcinoma (CCRF-CEM), colon 
adenocarcinoma (COLO 205), ovary adenocarcinoma (NIH:OVCAR-3) and gastric 
carcinoma (NCI-N87) cell lines were from the American Type Culture Collection (ATCC). 
Dulbecco's Modified Eagle Medium (DMEM) (Gibco, Grand Island NY, USA). Eagle 
Minimum Essential Medium (EMEM) and Roswell Park Memorial Institute 1640 (RPMI) 
medium (Nissui Pharm. Co., Ltd., Tokyo, Japan); McCoy’s 5A modified medium (Sigma, 
St. Louis, Mo., USA).  
Preparation of extracts and fractions 
The air-dried powdered leaves of Celtis australis  L. (1.5 kg) and Celtis occidentalis  L. 
(1.2 kg) were exhaustively extracted with 95% ethanol by percolation to give 225 g and 
200 g dry residue, respectively. An aliquot of the concentrated extracts (150 g, each) was 
suspended in distilled water and partitioned successively with petroleum ether (32 and 
34 g), CH2Cl2 (2 and 2.5 g), EtOAc (4 and 3.1 g), and n-BuOH (40 and 21 g).  
For the aqueous extract, 50 g of the air-dried powdered leaves was boiled with distilled 
water (3 times, each for 10 min). The extracts were then lyophilized to give 12 and 10 g, 
respectively. 
Fractionation and separation of major components of Celtis australis L. 
The n-BuOH soluble fraction (20 g) was chromatographed on a silica gel H 60, VLC (Ø7 x 
12.5 cm, 200 g) and eluted with CH2Cl2, gradients of CH2Cl2-EtOAc, EtOAc and gradients 
of EtOAc-MeOH up to pure MeOH. Fractions (200 mL, each) were collected and 
monitored by TLC. Similar fractions were pooled to give 6 collective fractions. Collective 
fraction 1 (2.1 g) was subjected to CC on polyamide using MeOH/H2O (20:80) v/v followed 
by CC on sephadex LH-20 using MeOH/(CH3)2CO/H2O (3:1:1) v /v/v to give compounds 1 
(16 mg), 2 (7 mg) and 3 (60 mg). Collective fraction 2 (2 g) was purified by CC on silica gel 
60 followed by CC on sephadex LH-20 using MeOH/(CH3)2CO/H2O (3:1:1) v/v/v to give 
compound  4  (20 mg). Collective fractions 3 (1.1 g) and 4 (4.2 g) were subjected to 
repeated CC on sephadex LH-20 using MeOH/H2O (50:50) v/v for elution to give 
compounds 5 (22 mg) and 6 (200 mg), respectively. Collective fraction 5 (750 mg) and 6 
(1.5 g) were subjected to repeated CC on sephadex LH-20 using MeOH/(CH3)2CO/H2O 
(3:1:1) v/v/v to give compounds 7 (19 mg) and 8 (28 mg). 
Fractionation and separation of major components of Celtis occidentalis L. 
The n-BuOH soluble fraction (15 g) was chromatographed on a silica gel H 60, VLC (Ø7 x 
12.5 cm, 190 g) and eluted with CH2Cl2, gradients of CH2Cl2-EtOAc, EtOAc and gradients 
of EtOAc-MeOH up to pure MeOH. Fractions (200 mL) were collected and monitored by 
TLC. Similar fractions were pooled to give 5 collective fractions. Collective fractions 1 
(0.7 g) and 2 (2.84 g) were subjected to CC on polyamide using MeOH/H2O (20:80) v/v 
followed by CC on sephadex LH-20 using MeOH/(CH3)2CO/H2O (3:1:1) v/v/v to give   Flavonoids from two Celtis species and their Biological Activities   971 
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compounds 1 (5 mg), 2 (21 mg) and 3 (80 mg). Collective fraction 3 (1.89 g) and 4 (1.56 g) 
were subjected to repeated CC on sephadex LH-20 using MeOH/H2O (50:50) v/v for 
elution followed by CC on sephadex LH-20 using MeOH/(CH3)2CO/H2O (3:1:1) v/v/v to 
give compounds 4 (16 mg) and 5 (8 mg), respectively. Collective fraction 5 (2.1 g) was 
subjected to repeated CC on sephadex LH-20 using MeOH (100%) for elution followed by 
CC on sephadex LH-20 using MeOH/(CH3)2CO/H2O (3:1:1) v/v/v to give compounds 6 
(22 mg), 7 (32 mg) and 8 (11 mg). 
4'''-Rhamnosyl-2''-O-β-D-galactopyranosylvitexin 
(6-Deoxy-α-L-mannopyranosyl-(1→4)-β-D-galactopyranosyl-(1→2)-(1S)-1,5-anhydro- 
1-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-8-yl]-D-glucitol, 8) 
Yellow powder, mp: 289–291 °C. Rf: 0.21 (EtOAc/MeOH/H2O, 100:16:13 and 2 drops 
formic acid). UV/Vis λmax (MeOH) nm: 272, 302sh, 330; (NaOMe): 280, 326, 393; (AlCl3): 
277, 304, 350, 382; (AlCl3/HCl): 278, 303, 344, 384; (NaOAc): 280, 310sh., 336sh., 390; 
(NaOAc/H3BO3): 274, 308, 351, 400sh. HR-ESI/MS:  m/z  = 739.2085 (M − H) (calcd 
739.2091), m/z = 741.2202 (M + H) (calcd 741.2210). 
1H and 
13C NMR: Table 1. 
Equipment 
Electrothermal 9100 equipment was used for melting point determination. UV spectra were 
measured using a Shimadzu UV 1650 PC spectrophotometer. ESI-MS (negative and 
positive modes) were determined on Thermo Finnigan (ion trap) equipment. NMR spectra 
were recorded in DMSO-d6 with a Varian Mercury instrument (
1HNMR, 300 MHz; 
13CNMR, 
75 MHz). Absorbance was measured on a multi well scanning spectrophotometer (Dynex 
MR 5000, Chantilly, VA, USA). 
In-vitro biological Evaluation 
DPPH radical scavenging activity 
The ability of the extracts to scavenge free radicals was determined according to the 
method of Hosny, et al 2002 [24]. In a 96-well plate, 10 μL of each sample or standard 
dissolved in ethanol (100 μg/mL) was added to 190 μL of 316 μM/mL DPPH solution. A 
blank was prepared using ethanol. After incubation at 30 °C for 30 min, the absorbance of 
each solution was measured at 517 nm. DL-α-tocopherol and BHT were used as positive 
controls. The scavenging activity of the samples was calculated as a percentage of free 
radical inhibition according to the formula:  
% inhibition = 
Ablank −  Asample
Ablank
 × 100 
where Ablank is the absorbance of the blank at zero time and Asample is the absorbance of 
the sample after 30 min. All experiments were carried out in triplicate. 
Xanthine oxidase-induced generation of superoxide radical 
The effect of the tested samples was measured according to the method described by Luis 
Gongora et al., 2003 [26] with slight modification. Superoxide was generated by oxidation 
of hypoxanthine (100 µM) with bovine milk xanthine oxidase in 1 mL of 10 mM KH2PO4-
KOH buffer, pH 7.4, and was detected by the reduction of nitroblue tetrazolium (NBT) at 
100 µM, followed spectrophotometrically at 560 nm. DL-α-tocopherol and BHT were used 972  T. S. El-Alfy et al.:   
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as positive controls. The effects of the test samples on enzyme activity was studied by 
measuring the uric acid formation from xanthine (2–25 µM) after 15 min incubation at 
25 °C, while absorbance was measured at 295 nm using allopurinol as a reference 
standard. The inhibitory activity of the tested samples and isolated compound in terms of 
IC50, i.e. the concentration required for 50% inhibition of uric acid formation was calculated 
by linear regression analysis. 
FeSO4/H2O2-stimulated lipid peroxidation in rat tissue homogenate [28, 29] 
Male Wistar rats (250–300 g) were sacrificed, and the rat tissues (brain, heart and liver: 
0.3–0.5 g) were rapidly removed and homogenized in 10 volumes of 15 mM Krebs buffer. 
Homogenates were centrifuged at 3000 x for 10 minutes at 4 °C to give supernatants 
containing (1.2 mg of protein/ ml; brain), (1.7 mg of protein/ ml; heart) and (2.5 mg of 
protein/ ml; liver) using Coomassie plus protein assay reagent and albumin standard as 
determined by the Bradford method [32]. During aerobic incubation of the tissue 
homogenates, MDA released reacts with thiobarbituric acid (TBA) to give a pink colour. 
The capability of the samples to inhibit MDA formation is used as a measure of their 
antioxidant activity. The pink colour complex of thiobarbituric acid reacting substance 
(TBARS) is measured at 532 nm for the test samples and positive standards (DL-α-
tocopherol and BHT) (200 μg/mL), as well as, 2''-O-β-galactopyranosylvitexin (100 μg/mL). 
The results were expressed as nanomoles of MDA equivalents per milligram of protein of 
rat (brain, heart and liver) homogenates. All measurements were done in triplicate. The 
capability to inhibit MDA formation was calculated using the following equation:  
Inhibition effects (%) = 1  − 
MDA in tissue homogenate with test extracts
MDA in tissue homogenate without test extracts
 × 100 
Cytotoxic activity 
Cell lines, HEP-G2, were cultured in DMEM containing 10% heat-inactivated FBS. CCRF-
CEM and NCI-N87 cells were cultured in RPMI1640 medium supplemented with 1% 
L-glutamine, 1% non-essential amino acids, 1% sodium pyruvate and 10% FBS. The 
COLO 205 human colon carcinoma cells were grown in McCoy’s 5A modified medium 
supplemented with 1% L-glutamine. NIH:OVCAR-3 cells were cultured in EMEM 
containing Earle's salts heated and sublimated with amino acids and 10% FBS. All cell 
lines were cultured in T75 Falcon flasks in a humidified atmosphere with 5% CO2, at 37°C. 
Cellular viability was determined using the standard MTT colorimetric assay [31]. The 
assay is based on reduction of MTT by the mitochondrial dehydrogenase of viable cells to 
give a blue formazan product that can be measured spectrophotometrically at 550 nm. The 
50 % effective dose (ED50) is calculated.  
Statistical Analysis 
All data were expressed as mean ± SE. Student’s t-test [33] was applied for detecting the 
significance of difference between each sample; P  <  0.05 was taken as the level of 
significance. 
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